ARCHIVES

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

This article is from The Cancer Letter archive.

Vol. 02 No. 01 | January 2, 1976

Download PDF Visit The Full Archive

Related Articles

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013